Nextblockbuster's Recent Posts
Title Rating Company Posted on ▼
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference 4 Zenith Epigenetics Jun 22, 2022 10:40AM
Re: My Rant - Limited attendance AGM, one way communication, vetted questions 1 Resverlogix Corp. Jun 21, 2022 11:07AM
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference 5 Zenith Epigenetics Jun 21, 2022 09:16AM
Re: Waiting for some great news about Zenith 3 Zenith Epigenetics Jun 19, 2022 08:19AM
Re: New insights from this study -- Questions for scientists. 4 Resverlogix Corp. Jun 10, 2022 07:19AM
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid 5 Resverlogix Corp. Jun 02, 2022 03:00PM
Re: BOD AGM 5 Resverlogix Corp. Jun 01, 2022 12:59PM
Re: For sake of argument lets say .. 4 Zenith Epigenetics Jun 01, 2022 06:58AM
Re: Where's the kool aid gang? 6 Resverlogix Corp. May 20, 2022 06:44PM
Re: Where's the kool aid gang? 3 Resverlogix Corp. May 20, 2022 11:45AM
Re: great,good,bad,ugly or so so?? 6 Resverlogix Corp. May 18, 2022 07:52PM
Re: Lobbying 5 Resverlogix Corp. May 17, 2022 08:36PM
Re: Q1- March 31, 2022 on SEDAR 1 Resverlogix Corp. May 14, 2022 08:22PM
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY 8 Resverlogix Corp. May 10, 2022 04:46PM
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY 4 Resverlogix Corp. May 09, 2022 12:27PM
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY 3 Resverlogix Corp. May 09, 2022 11:22AM
Re: Market Woes 8 Resverlogix Corp. May 02, 2022 09:31PM
Re: Sabizabulin - mCRPC- used now for Covid 19. 5 Zenith Epigenetics Apr 24, 2022 11:28AM
Re: BTD 6 Resverlogix Corp. Apr 23, 2022 03:10PM
Re: Sabizabulin - mCRPC- used now for Covid 19. 4 Zenith Epigenetics Apr 14, 2022 12:32PM